It's not really that surprising when you think about how this company has conducted it's business and the way it has treated it's Australian shareholders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
